Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study ...

The AI tool, StateViewer, helped researchers identify a person’s dementia type in 88% of cases, according to results newly ...

Premiering Tuesday in Philadelphia, "Facing the Wind" and it is a groundbreaking love story about people living with Lewy ...

A surprising new study suggests that dementia risk has declined with each generation. However, there are good reasons to be ...

One of the most common causes of dementia in younger people is Alzheimer’s disease. It works similarly to Alzheimer’s in ...

Smith, UT Tyler School of Nursing professor and assistant dean for professional development, said dementia is not a part of ...

A research team led by Associate Professor Ayako Okado-Matsumoto from the Department of Biology at Toho University has made a ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

A research team has made a significant finding that sheds new light on dementia with Lewy Bodies (DLB). The team was led by ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...